DUBLIN--(BUSINESS WIRE)--The "Non-Infectious Macular Edema Treatment: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Non-Infectious Macular Edema Treatment estimated at US$12.7 Billion in the year 2020, is projected to reach a revised size of US$18.6 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. Anti-VEGF, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$12.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Corticosteroids segment is readjusted to a revised 6.8% CAGR for the next 7-year period. The U.S. Market is Estimated at $3.8 Billion, While China is Forecast to Grow at 5.2% CAGR
The Non-Infectious Macular Edema Treatment market in the U.S. is estimated at US$3.8 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 5.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.
Immunosuppressants Segment to Record 6.2% CAGR
In the global Immunosuppressants segment, USA, Canada, Japan, China and Europe will drive the 6.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$979.8 Million in the year 2020 will reach a projected size of US$1.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year
Influencer Market Insights
World Market Trajectories
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS
4. GLOBAL MARKET PERSPECTIVE
For more information about this report visit https://www.researchandmarkets.com/r/vysqxr